Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Patrick Honore and David De Bels.
Connection Strength

17.395
  1. Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies. Crit Care. 2021 07 22; 25(1):259.
    View in: PubMed
    Score: 0.958
  2. Understanding the Underlying Mechanisms of Hyponatremia in Coronavirus Disease 2019 Is Critical Since Treatment Varies Based on Etiology: Let Us Not Forget Critical Illness-Related Corticosteroid Insufficiency As the Treatment Is Very Different and Often Lifesaving! Crit Care Med. 2021 07 01; 49(7):e724-e725.
    View in: PubMed
    Score: 0.954
  3. A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure! Chest. 2021 07; 160(1):e85-e86.
    View in: PubMed
    Score: 0.954
  4. Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two? Chest. 2021 07; 160(1):e88-e89.
    View in: PubMed
    Score: 0.954
  5. Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it? Intensive Care Med Exp. 2021 Mar 12; 9(1):16.
    View in: PubMed
    Score: 0.934
  6. SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy. Crit Care. 2020 10 22; 24(1):623.
    View in: PubMed
    Score: 0.909
  7. Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider. Crit Care. 2020 10 09; 24(1):603.
    View in: PubMed
    Score: 0.907
  8. TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction? Crit Care. 2020 10 06; 24(1):599.
    View in: PubMed
    Score: 0.907
  9. Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction? Crit Care. 2020 09 07; 24(1):551.
    View in: PubMed
    Score: 0.902
  10. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure. Crit Care. 2020 08 04; 24(1):482.
    View in: PubMed
    Score: 0.896
  11. Inhibiting IL-6 in COVID-19: we are not sure. Crit Care. 2020 07 27; 24(1):463.
    View in: PubMed
    Score: 0.894
  12. Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation. Crit Care. 2020 06 16; 24(1):352.
    View in: PubMed
    Score: 0.887
  13. With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes? Crit Care. 2020 05 18; 24(1):234.
    View in: PubMed
    Score: 0.883
  14. Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure. Crit Care. 2020 05 15; 24(1):226.
    View in: PubMed
    Score: 0.882
  15. Severe Acute Respiratory Syndrome Coronavirus-2-Associated Acute Kidney Injury: A Narrative Review Focused Upon Pathophysiology. Crit Care Med. 2021 05 01; 49(5):e533-e540.
    View in: PubMed
    Score: 0.236
  16. Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients. J Transl Int Med. 2020 12; 8(4):255-260.
    View in: PubMed
    Score: 0.230
  17. Case Report: Lung Ultrasound for the Guidance of Adjunctive Therapies in Two Invasively Ventilated Patients with COVID-19. Am J Trop Med Hyg. 2020 11; 103(5):1978-1982.
    View in: PubMed
    Score: 0.228
  18. Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue? Crit Care. 2019 09 05; 23(1):304.
    View in: PubMed
    Score: 0.210
  19. Endotoxin removal by polymyxin B: is it a question of dose or duration or both? Crit Care. 2019 09 04; 23(1):297.
    View in: PubMed
    Score: 0.210
  20. Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said! J Transl Int Med. 2019 09; 7(3):121-122.
    View in: PubMed
    Score: 0.209
  21. Improve short-term survival in postcardiotomy cardiogenic shock by simultaneous use of intra-aortic balloon pumping with veno-arterial extracorporeal membrane oxygenation: Beware of confounders! Ann Intensive Care. 2019 Jul 01; 9(1):77.
    View in: PubMed
    Score: 0.208
  22. Is interleukin-8 a true predictor of pediatric acute respiratory distress syndrome outcomes? Beware of potential confounders. Crit Care. 2019 06 27; 23(1):233.
    View in: PubMed
    Score: 0.207
  23. Attainment of therapeutic vancomycin level within the first 24 h. Crit Care. 2019 06 21; 23(1):228.
    View in: PubMed
    Score: 0.207
  24. Heparin-binding protein in sepsis: player! predictor! positioning? Ann Intensive Care. 2019 Jun 20; 9(1):71.
    View in: PubMed
    Score: 0.207
  25. Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration? Ann Intensive Care. 2019 Mar 08; 9(1):35.
    View in: PubMed
    Score: 0.203
  26. Acute oxygen delivery changes in relation to cardiac index changes after bolus fluid treatment in critically ill patients: Results of an observational study. J Clin Anesth. 2019 Nov; 57:9-10.
    View in: PubMed
    Score: 0.203
  27. Hemoadsorption therapy in the critically ill: solid base but clinical haze. Ann Intensive Care. 2019 Jan 31; 9(1):22.
    View in: PubMed
    Score: 0.202
  28. An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock. Curr Opin Crit Care. 2018 12; 24(6):463-468.
    View in: PubMed
    Score: 0.199
  29. Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? Crit Care. 2018 11 01; 22(1):289.
    View in: PubMed
    Score: 0.198
  30. Clinical benefit of high-volume hemofiltration in severe burn injury: is it removing bad humors or actually avoiding hypervolemia? Crit Care. 2018 11 01; 22(1):290.
    View in: PubMed
    Score: 0.198
  31. Citrate: How to Get Started and What, When, and How to Monitor? J Transl Int Med. 2018 09; 6(3):115-127.
    View in: PubMed
    Score: 0.197
  32. Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans? Ann Intensive Care. 2018 Sep 27; 8(1):96.
    View in: PubMed
    Score: 0.197
  33. Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an "endotoxin severity score" needed? Crit Care. 2018 08 17; 22(1):205.
    View in: PubMed
    Score: 0.195
  34. Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose. Crit Care. 2018 08 16; 22(1):207.
    View in: PubMed
    Score: 0.195
  35. Dexmedetomidine: the first new kid on the block for preventing cardiac surgery-associated acute kidney injury? Crit Care. 2018 06 05; 22(1):151.
    View in: PubMed
    Score: 0.193
  36. BPI fold-containing family a member 2 as a biomarker of acute kidney injury-close but no (clinical) cigar? Ann Transl Med. 2018 May; 6(10):191.
    View in: PubMed
    Score: 0.191
  37. Cardiogenic Shock after Nifedipine Administration in a Pregnant Patient: A Case Report and Review of the Literature. J Transl Int Med. 2018 09; 6(3):152-156.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.